Med. praxi. 2012;9(11):445-450
Cessation of ovarian function is associated with a significant reduction in plasma estrogen concentration that results in the development
of more or less serious somatic, functional, and mental changes. Early symptoms of estrogen deficiency in postmenopausal women
are most effectively managed with hormone replacement therapy. This year, ten years have elapsed since the publication of the initial
results of the Women's Health Initiative study that substantially altered the approach of both physicians and the public to influencing
the sequelae of menopause. The subsequent analyses and new findings became the basis for revising the decision-making process in
prescribing ET/EPT and recommending alternative means. Initiation of ET/EPT in the peri- and early postmenopausal periods with the
lowest possible effective doses minimizes adverse events and ensures a preponderance of benefit over risk. In the case of contraindications,
safer, but less effective nonhormonal alternatives can be recommended. Hormone replacement is not suitable for the prevention
and treatment of late sequelae of menopause.
Published: December 1, 2012 Show citation